GlassScriptPrepare for your visit
Anu Sehgal
Atlanta, GA · NPI 1740912823
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$464.50
in general payments reported to CMS, 2019-2025
Who reported paying
General payments only, top 4 by amount.
- Amgen INC. $149.37
- Glaxosmithkline, LLC. $124.99
- Genzyme Corporation $119.71
- Astrazeneca Pharmaceuticals LP $70.43
Drugs and devices associated with these payments
Kevzara Saphnelo Tavneos
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Anu Sehgal listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11684553/anu-sehgal